PHARMACOKINETICS OF UPADACITINIB IN PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS

被引：2
|
作者：
Qian, Y. [1 ]
Shmagel, A. [2 ]
Hao, S. [3 ]
Horneff, G. [4 ,5 ]
Brunner, H. [6 ]
Camp, H. [2 ]
Liu, W. [1 ]
Mohamed, M. E. [1 ]
机构：
[1] AbbVie Inc, Clin Pharmacol, N Chicago, IL USA
[2] AbbVie Inc, Immunol Dev, N Chicago, IL USA
[3] AbbVie Inc, Discovery & Exploratory Stat, N Chicago, IL USA
[4] Asklepios Clin Sankt Augustin, Dept Gen Paediat, St Augustin, Germany
[5] Univ Hosp Cologne, Dept Pediat & Adolescents Med, Cologne, Germany
[6] Cincinnati Childrens Hosp Med Ctr, Pediat Rheumatol Collaborat Study Grp PRCSG, Cincinnati, OH USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Targeted synthetic drugs; Clinical trials; Disease-modifying drugs; (DMARDs);
D O I：
10.1136/annrheumdis-2023-eular.3883
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0751
引用
收藏
页码：666 / 667
页数：2
相关论文
共 50 条
  • [21] Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss
    Miranda, LA
    Fischer, RG
    Sztajnbok, FR
    Johansson, A
    Figueredo, CMS
    Gustafsson, A
    JOURNAL OF PERIODONTOLOGY, 2005, 76 (01) : 75 - 82
  • [22] IMPACT OF TOFACITINIB TREATMENT ON HEIGHT IN JUVENILE IDIOPATHIC ARTHRITIS
    Brunner, H.
    Wasserman, H.
    Saul, M.
    Robinson, D.
    Nagy, E.
    Diehl, A.
    Mortezavi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 673 - 674
  • [23] Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study
    Heiligenhaus, Arnd
    Klotsche, Jens
    Tappeiner, Christoph
    Sengler, Claudia
    Niewerth, Martina
    Liedmann, Ina
    Hoeft, Sabine
    Walscheid, Karoline
    Lavric, Miha
    Foell, Dirk
    Minden, Kirsten
    RHEUMATOLOGY, 2019, 58 (06) : 975 - 986
  • [24] A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management
    Bansal, Nancy
    Pasricha, Chirag
    Kumari, Pratima
    Jangra, Sarita
    Kaur, Rupinder
    Singh, Ravinder
    AUTOIMMUNITY REVIEWS, 2023, 22 (07)
  • [25] Open issues in the assessment and management of pain in juvenile idiopathic arthritis
    Giancane, G.
    Alongi, A.
    Rosina, S.
    Calandra, S.
    Consolaro, A.
    Ravelli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : S123 - S126
  • [26] Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study
    Saraux, A.
    Benichou, J.
    Guillevin, L.
    Idbrik, L.
    Job-Deslandre, C.
    Sibilia, J.
    Soudant, M.
    Wendling, D.
    Guillemin, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (05) : 602 - 610
  • [27] Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?
    Ting, T. V.
    Lovell, D. J.
    Levinson, Joseph E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (07): : 344 - 345
  • [28] Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?
    Muller, Petra C. E. Hissink
    Yildiz, Bahar
    Allaart, Cornelia F.
    Brinkman, Danielle M. C.
    van Rossum, Marion
    van Suijlekom-Smit, Lisette W. A.
    van den Berg, J. Merlijn
    ten Cate, Rebecca
    de Vries, Martine C.
    BMC MEDICAL ETHICS, 2018, 19
  • [29] SAFETY PROFILE OF UPADACITINIB UP TO 6.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Cohen, S. B.
    Van Vollenhoven, R.
    Curtis, J.
    Calabrese, L.
    Zerbini, C.
    Tanaka, Y.
    Bessette, L.
    Richez, C.
    Strengholt, S.
    Coombs, D.
    Khan, N.
    Gara, A.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 709 - 710
  • [30] Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry
    Drechsel, Paula
    Stuedemann, Katrin
    Niewerth, Martina
    Horneff, Gerd
    Fischer-Betz, Rebecca
    Seipelt, Eva
    Spaehtling-Mestekemper, Susanna
    Aries, Peer
    Zink, Angela
    Klotsche, Jens
    Minden, Kirsten
    RHEUMATOLOGY, 2020, 59 (03) : 603 - 612
12345